• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Cautious Optimism for More M&A Activity in 2013

    Growing corporate cash balances and slowing organic-growth opportunities could lead to increased deal volume this year even if economic uncertainty throttles some activity, says Morningstar's Bridget Freas.

  2. Personalized Medicine is the Future

    Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.